XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.540
-0.035 (-1.36%)
At close: Apr 28, 2026, 4:00 PM EDT
2.545
+0.005 (0.20%)
After-hours: Apr 28, 2026, 4:10 PM EDT
XBiotech Market Cap
XBiotech has a market cap or net worth of $77.44 million as of April 28, 2026. Its market cap has decreased by -11.80% in one year.
Market Cap
77.44M
Enterprise Value
-48.11M
1-Year Change
-11.80%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $77.44M, a decrease of -89.50%. That is a compound annual growth rate of -18.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 78.50M | 7.68% |
| Dec 31, 2025 | 72.90M | -39.45% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 80.95M |
| Gain Therapeutics | 78.15M |
| Alterity Therapeutics | 78.00M |
| aTyr Pharma | 77.81M |
| MAIA Biotechnology | 75.84M |
| ImmuCell | 75.81M |
| PMV Pharmaceuticals | 75.73M |
| TScan Therapeutics | 75.73M |